Stayble Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Stayble Therapeutics has a total shareholder equity of SEK16.5M and total debt of SEK850.0K, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are SEK21.7M and SEK5.2M respectively.
Key information
5.1%
Debt to equity ratio
kr850.00k
Debt
| Interest coverage ratio | n/a |
| Cash | kr14.08m |
| Equity | kr16.51m |
| Total liabilities | kr5.19m |
| Total assets | kr21.70m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: STABL's short term assets (SEK16.1M) exceed its short term liabilities (SEK4.3M).
Long Term Liabilities: STABL's short term assets (SEK16.1M) exceed its long term liabilities (SEK850.0K).
Debt to Equity History and Analysis
Debt Level: STABL has more cash than its total debt.
Reducing Debt: STABL's debt to equity ratio has reduced from 12% to 5.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: STABL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: STABL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.4% each year